期刊文献+

单中心360例胰腺导管内乳头状黏液瘤术后病理学特征与预后相关性研究

Association of pathological characteristics and prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas: A study based on a single institution with 360 patients
原文传递
导出
摘要 目的明确胰腺导管内乳头状黏液瘤(IPMNs)病理学特征与预后的相关性,并结合IPMNs伴浸润癌(INV-IPMNs)病理学特征优化病人的分层。方法回顾性分析海军军医大学长海医院肝胆胰腺外科2012年1月至2018年12月360例术后病理学诊断为IPMNs的病人的临床资料。采用Kaplan-Meier法分析IPMNs病理学特征与预后的关系,Logistic回归分析INV-IPMNs独立相关因素。对TNMⅡ或Ⅲ期、G3、R1、神经侵犯、脉管侵犯、胰胆管型/肠型6个病理学指标单独赋值为1,评价病人病理学指标赋值总分预测预后的价值。结果浸润型癌(P<0.001)和胰胆管型(P=0.019)是IPMNs预后不良的主要危险因素。病变位于胰体尾较胰头颈钩突进展为INV-IPMNs的风险显著降低(OR=0.41,95%CI 0.23-0.72,P=0.002),多发部位病变较胰头颈钩突进展为INVIPMNs风险显著增高(OR=7.60,95%CI 1.90-30.35,P=0.004)。肠型(OR=4.83,95%CI 2.71-8.64,P<0.001)、胰胆管型(OR=12.05,95%CI 5.72-25.4,P<0.001)较胃型进展为浸润型癌的风险显著增高。病理学指标赋值总分0-1分、2分和≥3分3层分级可有效预测INV-IPMNs的预后(P=0.002)。结论INV-IPMNs的3级分层可有效预测预后,有助于指导病人术后精准管理。 ObjectiveTo clarify the association of pathological characteristics and prognosis in patients withintraductal papillary mucinous neoplasms(IPMNs)and to stratify the invasive IPMNs based on the prognosis.Methods A retrospective analysis of 360 patients,who received surgery and were pathologically identified as IPMNs,wasperformed.The association of pathological characteristics and prognosis was analysed by Kaplan-Meier.Theindependent association factor for invasive IPMNs was done by Logistic regression analysis.TNM stageⅡ/Ⅲ,G3,R1,perineural invasion,lymphvascular invasion and pancreatobiliary subtype were aasigned score 1 respectively and therelationship of total score and prognosis was evaluated.ResultsInvasive carcinoma(P<0.001)and pancreatobiliarysubtype(P=0.019)are the main risk factors for poor prognosis in patients with IPMNs.Compared with tumor located inhead,neck and uncinate process of pancreas type,tumor located in body and tail has a lower risk of progression toinvasive IPMNs[OR=0.41,95%confidential interval(CI)0.23-0.72,P=0.002],whereas does multiple tumors ofpancreas have a higher risk of progression to invasive IPMNs(OR=7.60,95%CI 1.90-30.35,P=0.004).Compared withgastric subtype,intestinal subtype(OR=4.83,95%CI 2.71-8.64,P<0.001)andpancreatobiliary subtype(OR=12.05,95%CI 5.72-25.4,P<0.001)has a higher risk of progression to invasive IPMNs.The 3 grade of total score of 0-1,2 and≥3 can predict the over survival of patients with invasive IPMNs efficiently(P=0.002).ConclusionThe newstratification could successfully predict prognosisof patients with invasive IPMNs and it may faciliatethe precise management of invasive IPMNs aftersurgery.
作者 李勃 张国虓 时霄寒 沈硕 高绥之 潘亚奇 郭世伟 金钢 LI Bo;ZHANG Guo-xiao;SHI Xiao-han(Department of Hepatobiliary Pancreatic Surgery,Changhai Hospital Affiliated to Navy Medical University,Shanghai 200433,China;Beidaihe Rehabilitation and Recuperation Center of PLA,Qinhuangdao 066100,China)
出处 《中国实用外科杂志》 CAS CSCD 北大核心 2021年第2期164-169,共6页 Chinese Journal of Practical Surgery
基金 国家自然基金面上项目(No.81972913)
关键词 胰腺导管内乳头状黏液瘤 预后 病理 intraductal papillary mucinous neoplasms prognosis pathology
  • 相关文献

参考文献2

二级参考文献19

  • 1Salvia R, Malleo G, Marchegiani G, et al. Pancreatic resections for cystic neoplasms: From the surgeon' s presumption to the pa-thologist's reality[J]. Surgery, 2012,152(3 suppl 1):135-142.
  • 2Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas tumor growth rates and recommendations for treat- ment[J]. Ann Surg ,2005,242(3): 413-421.
  • 3Malleo G, Bassi C, Rossini R, et al. Growth pattern of serous cys- tic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommenda- tions for treatment [ J ]. Gut ,2012,61 (5):746-751.
  • 4Brugge WR, Lewandrowski K, Lee-Lewandrowski, et al. Diagno- sis of pancreatic cystic neoplasms: A report from the Cooperative Pancreatic Cyst Study [J]. Gastroenterology, 2004, 126(5): 1330-1336.
  • 5Brient C, Regenet N, Sulpice L, et al. Risk factors for postopera- tive pancreatic fistulization subsequent to enueleation [ J ]. J Gas- trointest Surg, 2012,16(10):1883-1887.
  • 6Beger HG, Schwarz M, Poch B. How I Do It: Duodenum-pre- serving total pancreatic head resection for benign cystic neoplas- tic lesions [ J ]. J Gastrointest Surg ,2012,16( 11 ):2160-2166.
  • 7Masao Tanaka, Suresh Chari, Volkan Adsay, et al. Internationalconsensus guidelines for management of intraductal papillarymucinous neoplasms and mucinous cystic neoplasms of the pan—creas[J]. Pancreatology, 2006,6(1 -2): 17-32.
  • 8Bin Xu, Wen-Yan Zheng, Da-Yong Jin ,et al. Predictive valueof serum carbohydrate antigen 19-9 in malignant intraductalpapillary mucinous neoplasms [j]. World J Surg, 2011,35(5):1103-1109.
  • 9Ingkakul T, Sadakari Y, lenaga J, et al. Predictors of the pres-ence of concomitant invasive ductal carcinoma in intraductalpapillary mucinous neoplasm of the pancreas [J]. Ann Surg,2010,251(1):70-75.
  • 10Tang RS,Weinberg B,Dawson DW, et al.Evaluation of the guide-lines for management of pancreatic branch-duct intraductal pap-illary mucinous neoplasm[j]. Clin Gastroenterol Hepatol, 2008,6(7):815-819.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部